Update on Immunotherapeutic Strategies for Advanced Merkel Cell Carcinoma

To claim CME/NCPD credit for this podcast, visit i3health.com/advanced-merkel-cell-carcinoma In this bonus episode of Oncology Data Advisor, learn more about emerging evidence on immunotherapeutic strategies for advanced MCC and multidisciplinary approaches to monitor and manage immune-related adverse events in patients with advanced MCC in this activity presented by Shaildender Bhatia, MD, and Ciara Kelly, MBBCh, BAO. Listen now to earn CME/NCPD!